Our data revealed that IL-17C is minimally expressed in HNSCC; however, both of its receptors are expressed at varying levels in HNSCC cancer cells, suggesting that these cells could serve as suitable targets for IL-17C stimulation. The gene discussed is IL17C; the disease is cancer.